v3.20.1
Segment Information - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Disaggregation of Revenue    
Total net revenues $ 8,619 $ 7,828
All other    
Disaggregation of Revenue    
Net revenues 105 101
Immunology | HUMIRA    
Disaggregation of Revenue    
Net revenues 4,703 4,446
Immunology | HUMIRA | United States    
Disaggregation of Revenue    
Net revenues 3,656 3,215
Immunology | HUMIRA | International    
Disaggregation of Revenue    
Net revenues 1,047 1,231
Immunology | SKYRIZI    
Disaggregation of Revenue    
Net revenues 300 0
Immunology | SKYRIZI | United States    
Disaggregation of Revenue    
Net revenues 266 0
Immunology | SKYRIZI | International    
Disaggregation of Revenue    
Net revenues 34 0
Immunology | RINVOQ    
Disaggregation of Revenue    
Net revenues 86 0
Immunology | RINVOQ | United States    
Disaggregation of Revenue    
Net revenues 82 0
Immunology | RINVOQ | International    
Disaggregation of Revenue    
Net revenues 4 0
Hematologic Oncology | IMBRUVICA    
Disaggregation of Revenue    
Net revenues 1,232 1,022
Hematologic Oncology | IMBRUVICA | United States    
Disaggregation of Revenue    
Net revenues 966 829
Hematologic Oncology | IMBRUVICA | International    
Disaggregation of Revenue    
Collaboration revenues 266 193
Hematologic Oncology | VENCLEXTA    
Disaggregation of Revenue    
Net revenues 317 151
Hematologic Oncology | VENCLEXTA | United States    
Disaggregation of Revenue    
Net revenues 201 105
Hematologic Oncology | VENCLEXTA | International    
Disaggregation of Revenue    
Net revenues 116 46
HCV | MAVYRET    
Disaggregation of Revenue    
Net revenues 559 790
HCV | MAVYRET | United States    
Disaggregation of Revenue    
Net revenues 234 403
HCV | MAVYRET | International    
Disaggregation of Revenue    
Net revenues 325 387
HCV | VIEKIRA | International    
Disaggregation of Revenue    
Net revenues 5 25
Other Key Products | Creon | United States    
Disaggregation of Revenue    
Net revenues 276 227
Other Key Products | Lupron    
Disaggregation of Revenue    
Net revenues 233 229
Other Key Products | Lupron | United States    
Disaggregation of Revenue    
Net revenues 195 191
Other Key Products | Lupron | International    
Disaggregation of Revenue    
Net revenues 38 38
Other Key Products | Synthroid | United States    
Disaggregation of Revenue    
Net revenues 205 182
Other Key Products | Synagis | International    
Disaggregation of Revenue    
Net revenues 270 287
Other Key Products | Duodopa    
Disaggregation of Revenue    
Net revenues 124 111
Other Key Products | Duodopa | United States    
Disaggregation of Revenue    
Net revenues 25 22
Other Key Products | Duodopa | International    
Disaggregation of Revenue    
Net revenues 99 89
Other Key Products | Sevoflurane    
Disaggregation of Revenue    
Net revenues 79 92
Other Key Products | Sevoflurane | United States    
Disaggregation of Revenue    
Net revenues 16 17
Other Key Products | Sevoflurane | International    
Disaggregation of Revenue    
Net revenues 63 75
Other Key Products | Kaletra    
Disaggregation of Revenue    
Net revenues 86 78
Other Key Products | Kaletra | United States    
Disaggregation of Revenue    
Net revenues 14 13
Other Key Products | Kaletra | International    
Disaggregation of Revenue    
Net revenues 72 65
Other Key Products | ORILISSA    
Disaggregation of Revenue    
Net revenues 31 13
Other Key Products | ORILISSA | United States    
Disaggregation of Revenue    
Net revenues 30 13
Other Key Products | ORILISSA | International    
Disaggregation of Revenue    
Net revenues 1 0
Other Key Products | AndroGel | United States    
Disaggregation of Revenue    
Net revenues $ 8 $ 74